U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C12H16O3
Molecular Weight 208.2536
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of .BETA.-ASARONE

SMILES

COC1=CC(OC)=C(OC)C=C1\C=C/C

InChI

InChIKey=RKFAZBXYICVSKP-WAYWQWQTSA-N
InChI=1S/C12H16O3/c1-5-6-9-7-11(14-3)12(15-4)8-10(9)13-2/h5-8H,1-4H3/b6-5-

HIDE SMILES / InChI

Molecular Formula C12H16O3
Molecular Weight 208.2536
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/29042206 | https://www.ncbi.nlm.nih.gov/pubmed/29032344 | https://www.ncbi.nlm.nih.gov/pubmed/15679319 | https://www.ncbi.nlm.nih.gov/pubmed/25311563 |

α-Asarone is a phytochemical compound with neuroprotective, anti-oxidative, anticonvulsive and cognitive enhancing action, isolated from the Chinese medicinal herb Acorus tatarinowii. Numerous clinical studies in China had indicated the effectiveness of α-asarone against respiratory disorders and epilepsy. Asarone tablets have been clinically used as bronchial asthma and bronchitis prescription drug in China. Unfortunately, toxic and genotoxic studies of a-asarone have indicated that this compound may pose a risk to human health, including embryotoxicity and maternal toxicity in rats, hepatotoxicity in rat-cultivated hepatocytes, and in vivo and in vitro genotoxic damage in mammalian cells.

CNS Activity

Curator's Comment: Known to be CNS penetrant in mouse. Human data not available

Originator

Sources: Berichte der Deutschen Chemischen Gesellschaft 22, 3172-6

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
92.3 µM [IC50]
5.86 µM [IC50]
Conditions

Conditions

PubMed

PubMed

TitleDatePubMed
Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal.
2018 Jan 5
Patents

Patents

Sample Use Guides

ICR mice/ Male: 10,15,20, 30, 50 and 100mg/kg i.p. Swiss albino mice/male: 1. 7, 3.5, 7, and 14; p.o.; o.d.× 7 days SD rats/ male: 50, 100 and 200; i.p.; o.d.× 21 days Wistar rats/male: 20 mg/kg, i.v.
Route of Administration: Other
BV-2 microglial cells were used for activity evaluation. Cells were cultured in DMEM supplemented with 5% FBS and 50 mkg/mL penicillin-streptomycin in a 37 C humidified incubator supplied with 5% CO2 and 95% O2. The cells were seeded at a density of 5 x 10^4 cells/mL and were pretreated for 1 h with various concentrations of a-asarone (10, 50 and 250 mkM) followed by an incubation with LPS (100 ng/mL) for the indicated times (30 min and 6, 18 and 24 h).
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:06:21 GMT 2025
Edited
by admin
on Mon Mar 31 20:06:21 GMT 2025
Record UNII
IGA3MH6IUW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(Z)-ASARONE
Preferred Name English
.BETA.-ASARONE
Systematic Name English
BENZENE, 1,2,4-TRIMETHOXY-5-(1Z)-1-PROPENYL-
Systematic Name English
CIS-.BETA.-ASARONE
Systematic Name English
1,2,4-TRIMETHOXY-5-PROPENYLBENZENE, Z-
Systematic Name English
BETA-ASARONE
Systematic Name English
CIS-ISOELEMICIN
Systematic Name English
BENZENE, 1,2,4-TRIMETHOXY-5-PROPENYL-, (Z)-
Common Name English
BENZENE, 1,2,4-TRIMETHOXY-5-(1-PROPENYL)-, (Z)-
Common Name English
(Z)-5-PROPENYL-1,2,4-TRIMETHOXYBENZENE
Systematic Name English
(Z)-1,2,4-TRIMETHOXY-5-(1-PROPENYL)BENZENE
Systematic Name English
CIS-ISOASARONE
Common Name English
.BETA.-ASARONE, CIS-
Systematic Name English
2,4,5-TRIMETHOXYPROPEN-1-YLBENZENE
Systematic Name English
BENZENE, 1,2,4-TRIMETHOXY-5-(1Z)-1-PROPEN-1-YL-
Systematic Name English
Classification Tree Code System Code
JECFA EVALUATION BETA-ASARONE
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
Code System Code Type Description
PUBCHEM
5281758
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
CAS
5273-86-9
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
EPA CompTox
DTXSID601020057
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
ECHA (EC/EINECS)
226-096-6
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
CHEBI
10353
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
WIKIPEDIA
ASARONE
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
FDA UNII
IGA3MH6IUW
Created by admin on Mon Mar 31 20:06:21 GMT 2025 , Edited by admin on Mon Mar 31 20:06:21 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
In view of the toxic properties documented for the oil and associated with beta-asarone, it has been recommended that only beta-asarone-free calamus root should be used in phytotherapy.